To view this email as a web page, click here.
 
FDA ACTIONS
 
Costly new ALS treatment approved
FDA recently approved the first new treatment for amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease, in more than 20 years.
Read more
 
FDA approves first targeted leukemia drug, plus 2 more
FDA approved a new drug to treat acute myeloid leukemia (AML) and approved the first treatment for Batten disease, while expanding the use of a current drug to treat liver cancer.
Read more
 
New abuse-deterrent opioid available
A new abuse-deterrent painkiller — oxycodone hydrochloride (RoxyBond) — will be available soon after receiving FDA approval.
Read more
 
ADVERTISEMENT
Ad description here
 

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.